Stockreport

Amgen's SCLC drug gets orphan status [Seeking Alpha]

Amgen Inc.  (AMGN) 
Last amgen inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.amgen.com
PDF The FDA grants orphan drug designation to Amgen's (NASDAQ: AMGN ) treatment for small cell lung cancer. The generic name is bispecific T-cell engager antibody [Read more]